company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1834000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7702000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9536000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7572000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7523000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57900000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57900000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59278000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q1,2010-07-01,2010-09-30,2011-11-08 17:24:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2824000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2824000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2824000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2093000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8256000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10349000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7525000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7499000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59715000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59715000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57700000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q2,2010-10-01,2010-12-31,2012-02-09 16:50:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2059000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2059000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2059000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2692000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8649000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11341000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9282000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,65000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9217000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9217000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9217000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9217000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59931000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59931000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61400000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q3,2011-01-01,2011-03-31,2012-05-10 15:49:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1386000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1386000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1386000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11631000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9875000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9125000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12381000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10995000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10964000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59973000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59973000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59700000.0
Pharmacyclics Inc ,PCYC,,0000949699,2011.0,Q4,2011-04-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3350000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11248000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14598000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14561000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,23000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14538000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14538000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14538000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14538000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68323000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68323000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69200000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q1,2011-07-01,2011-09-30,2012-11-07 16:43:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,77903000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,77903000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77903000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3944000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12076000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16020000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61883000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61904000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5651000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56253000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56253000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56253000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68658000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71725000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68600000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q2,2011-10-01,2011-12-31,2012-02-09 16:50:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1927000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1927000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1927000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4061000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15828000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19889000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17962000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,56000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17906000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5083000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12823000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12823000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12823000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68848000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68848000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67500000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:13:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2123000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2123000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2123000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4220000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15385000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19605000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17482000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,47000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17435000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-529000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16906000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16906000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16906000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68728000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72617000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
Pharmacyclics Inc ,PCYC,,0000949699,2012.0,Q4,2012-04-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q1,2012-07-01,2013-03-31,2014-05-07 21:53:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54684000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54684000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,54684000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14730000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27923000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42653000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12031000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-133000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12008000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-343000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12351000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12351000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12351000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72953000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77194000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72700000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:11:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79088000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79088000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79088000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14742000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10920000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25662000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53426000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,148000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,148000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53574000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11241000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42333000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42333000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42333000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73316000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77659000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73000000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:51:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126397000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126397000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3501000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3501000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,122896000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44139000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46290000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90429000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32467000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,87000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32554000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20228000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12326000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12326000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12326000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72777000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77083000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72800000.0
Pharmacyclics Inc ,PCYC,,0000949699,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,119377000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,119377000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6110000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6110000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,113267000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34715000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35292000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25035000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95042000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18225000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,80000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-42000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18263000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18275000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18275000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18275000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74754000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78064000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76100000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 17:04:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,113020000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,113020000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9305000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9305000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103715000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45002000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45668000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,154000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,50095000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,140919000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37204000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-116000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37238000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-181000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37057000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37057000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37057000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75139000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75139000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75600000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 18:11:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207140000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207140000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11622000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11622000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,195518000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37978000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43995000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,183000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,64993000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,147149000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,48369000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48370000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6948000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41422000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,41422000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41422000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75392000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78205000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75300000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 16:51:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,290192000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,290192000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13373000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13373000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,276819000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50260000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47504000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,183000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85881000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,183828000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,92991000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,277000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-216000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,61000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,93052000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29568000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63484000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63484000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63484000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75247000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78151000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75500000.0
Pharmacyclics Inc ,PCYC,,0000949699,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,205772000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,205772000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16702000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16702000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,189070000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49505000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49377000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,179000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,86228000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,185289000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3781000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,167000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,285000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,452000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4233000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,86000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4147000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4147000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4147000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76205000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79231000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82900000.0
Pharmacyclics Inc ,PCYC,,0000949699,2015.0,Q1,2015-01-01,2015-03-31,2015-05-04 17:04:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
